These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 678695

  • 1. Mathematical analysis of cancer chemotherapy: the effects of chemotherapeutic agents on the cell cycle traverse.
    Chuang SN, Soong TT.
    Bull Math Biol; 1978; 40(4):499-512. PubMed ID: 678695
    [No Abstract] [Full Text] [Related]

  • 2. Factors influencing the recovery from potentially lethal damage (PLD) in mammalian cells in vitro and in vivo.
    Bertrand M, Deen DF.
    Cancer Treat Rev; 1980 Mar; 7(1):1-15. PubMed ID: 7397705
    [No Abstract] [Full Text] [Related]

  • 3. Effects of treatment with DNA-directed cancer chemotherapeutic agents after polyamine depletion.
    Marton LJ.
    Pharmacol Ther; 1987 Mar; 32(2):183-90. PubMed ID: 3110798
    [No Abstract] [Full Text] [Related]

  • 4. Comparative effects of vincristine and vindesine on cell cycle kinetics in vitro.
    Hill BT, Whelan RD.
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():5-15. PubMed ID: 6159973
    [No Abstract] [Full Text] [Related]

  • 5. Cell cycle and effect of antineoplastic drugs: facts and pitfalls.
    Mauro F, Spanò M, Teodori L, Drewinko B, Barlogie B.
    Prog Clin Biol Res; 1983 Sep; 132C():199-209. PubMed ID: 6634772
    [No Abstract] [Full Text] [Related]

  • 6. Kinetics of minimal residual disease.
    Salmon SE.
    Recent Results Cancer Res; 1979 Sep; 67():1-15. PubMed ID: 451317
    [No Abstract] [Full Text] [Related]

  • 7. [Cell kinetic studies on human melanoma cell line (SEKI II) under the effect of chemotherapeutic agents (author's transl)].
    Shimada S, Kawashima M, Watanabe S, Yamada K, Mizoguchi M, Hori Y, Kukita A.
    Nihon Hifuka Gakkai Zasshi; 1980 Aug; 90(9):825-31. PubMed ID: 6968840
    [No Abstract] [Full Text] [Related]

  • 8. Cell cycle specificity of anticancer agents.
    van Putten LM.
    Antibiot Chemother (1971); 1978 Aug; 23():128-34. PubMed ID: 348073
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical concepts derived from animal chemotherapy studies.
    Goldin A, Schabel FM.
    Cancer Treat Rep; 1981 Aug; 65 Suppl 3():11-9. PubMed ID: 7049366
    [Abstract] [Full Text] [Related]

  • 12. Telomerase: an unusual target for cytotoxic agents.
    Corey DR.
    Chem Res Toxicol; 2000 Oct; 13(10):957-60. PubMed ID: 11080041
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combination chemotherapy--theory and practice.
    Capizzi RL, Keiser LW, Sartorelli AC.
    Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
    [No Abstract] [Full Text] [Related]

  • 17. [Value of experimental results in clinical tumor chemotherapy (author's transl)].
    Somfai-Relle S, Sugár J.
    Arch Geschwulstforsch; 1980 Jun; 50(2):132-40. PubMed ID: 7436697
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cellular effects of cancer chemotherapy administration.
    Moran P.
    J Intraven Nurs; 2000 Jun; 23(1):44-51. PubMed ID: 11013533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.